MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway

Chao Fang(Central South University), Zhaoqian Liu(Central South University)
Scientific Reports
January 11, 2017
Cited by 84


Related Papers